Received Jul 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | U8494AA | SC / RA |
On 07/15/2025 Patient, DOB 04/XX/20XX (MRN withheld) was seen in clinic by provider for a new patient visit including Vaccines. Patient was due for his MCV 4 , Hep A, and HPV. Mother of the patient was given VIS prior to administration and the VAR was completed. Patients Hep A and Hpv vaccines were administered Intramuscular without issue. While his MCV 4 was administered Subcutaneous without issue. His MCV4 was discovered to be incorrectly administered Subcutaneously shortly after administering the dose. I quickly alerted Provider of the error, and we referred to the CDC website for direction on next steps. Per the CDC the vaccine does not need to be administered. I referred to the standing order for guidance as well. And precautionarily consulted with (withheld name). I was told by both providers that administering in the cite I did would cause slow absorption. Per protocol I also reached out to the patient/ parent of the patient to inform of this incident however the patient was unable to be reached. I also notified my immediate supervisor (name withheld) of the incident. In addition I also reported on VAERS. My goal in the future is to be more mindful of what medication I am administering and where.
None
none
no Medications at time of Vaccination
NKA